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Malformations Independently of Vascular
Smooth Muscle Cell Function
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Numerous in vitro and in vivo studies implicate transforming growth factor-b (TGFb) superfamily signaling in vascular
development and maintenance. Mice and humans with mutations in TGFb superfamily signaling pathway genes exhibit a
range of vascular defects that include dilated, fragile and hemorrhagic vessels, defective angiogenic remodeling, severe
vascular malformations including arterio-venous malformations, and disrupted vascular smooth muscle cell recruitment
and maintenance. Despite a wealth of data, the functions of TGFb superfamily signals during angiogenesis are poorly
defined, since early embryonic lethality and difficulty distinguishing between primary and secondary defects frequently
confound phenotypic interpretation. To perturb TGFb superfamily signaling during angiogenesis, we have misexpressed
Smad7, an intracellular antagonist of TGFb superfamily signaling, in the developing chick limb and head. We find that the
great vessels are strikingly dilated and frequently develop intra and intervascular shunts. Neither noggin nor dominant
negative BMP receptor misexpression causes similar vascular phenotypes. However, simultaneous misexpression of
constitutively active BMP receptors with Smad7 suppresses the Smad7-induced phenotype, suggesting that a BMP-like
intracellular pathway is the target of Smad7 action. Despite the gross morphological defects, further analyses find no
evidence of hemorrhage and vessel structure is normal. Furthermore, enlarged vessels and vascular malformations form in
either the presence or absence of vascular smooth muscle, and vascular smooth muscle cell recruitment is unperturbed. Our
data define the TGFb superfamily pathway as an integral regulator of vessel caliber that is also essential for appropriate
vessel connectivity. They demonstrate that dilation need not result in vessel rupture or hemorrhage, and dissociate vessel
maintenance from the presence of a vascular smooth muscle cell coat. Furthermore they uncouple vascular smooth muscle
cell recruitment and differentiation from TGFb superfamily signaling. © 2001 Elsevier Science
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The vascular network of the embryo, and ultimately of
the adult, originates in early embryonic development from
a small population of mesodermal endothelial precursor
cells. During vasculogenesis, endothelial cell precursors
coalesce to form a capillary plexus that is subsequently
remodeled as vessels enlarge, as arterial-venous distinctions
are established and as mural cells, such as capillary-
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All rights reserved.associated pericytes and vascular smooth muscle cells
(VSMC), are recruited. Later, during angiogenesis, new
vessels are generated from existing ones and are similarly
remodeled (Daniel and Abrahamson, 2000; Hungerford and
Little, 1999; Risau, 1997; Yancopoulos et al., 2000). These
processes are molecularly distinguishable as angiogenesis
requires intercellular signals, such as the angiopoietins and
their receptors, that appear to be dispensable for normal
vasculogenesis (Gale and Yancopoulos, 1999; Puri et al.,
1995; Sato et al., 1995; Suri et al., 1996; Vikkula et al., 1996;
Yancopoulos et al., 2000). During development the vessels
of the developing head, body and extraembryonic regions
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angiogenesis. The developing limb is predominantly vascu-
larized by angiogenesis, as new vessels sprout from pre-
existing flank vessels and invade the nascent limb bud
(Ambler et al., 2001; Brand-Saberi et al., 1995; Coffin and
Poole, 1988; Daniel and Abrahamson, 2000; Pardanaud et
al., 1987; Pardanaud et al., 1989; Poole and Coffin, 1989;
Risau, 1997).
TGFb superfamily ligands of the TGFb, activin, and bone
morphogenetic protein (BMP) families stimulate hetero-
meric serine/threonine kinase receptors to activate Smad
protein-mediated intracellular signal transduction. Phos-
phorylated positive Smad proteins hetero-oligomerize with
a common partner, Smad4, translocate to the nucleus and
regulate target gene expression (Massague, 1998; Massague
and Chen, 2000; Miyazono, 2000). Specificity is imparted
through differential ligand binding by the receptors, and
subsequently activation of pathway-specific positive
Smads. Thus, for example, BMPs activate two signaling
receptors, BMPR Ia and BMPR Ib (Alk3 and Alk6), that in
turn activate Smad1, Smad5 and Smad8, but not Smad2 or
Smad3, which are regulated by TGFb and activin ligands
and their cognate receptors (Eppert et al., 1996; Hoodless et
al., 1996; Massague and Chen, 2000).
Multiple TGFb superfamily ligands, receptors and signal-
ing proteins are expressed in association with the develop-
ing vasculature and have multiple functions during vascu-
lar development (Gatherer et al., 1990; Pelton et al., 1989;
Pelton et al., 1990; Roberts and Sporn, 1992; Schmid et al.,
1991). In vitro studies suggest that TGFb influences endo-
thelial cell growth, regulates extracellular matrix deposi-
tion, modulates endothelial cell migration and fusion into
capillary tubes, and controls vessel lumen size (Gajdusek et
al., 1993; Madri et al., 1988; Merwin et al., 1990; Pepper et
al., 1990; Pepper et al., 1993; Pepper, 1997; Roberts and
Sporn, 1989). However, the nature of the endothelial cell
response to added TGFb ligand can vary dramatically de-
pending on experimental design, thus making specific func-
tional assignments difficult (Daniel and Abrahamson, 2000;
Klagsbrun and D’Amore, 1991).
Recent studies have focused on in vivo loss of function
analyses to define roles of this pathway in vascular devel-
opment. Loss of individual signaling components can lead
to severe vascular defects resulting in embryonic lethality
either during initial vasculogenesis, or in the early stages of
angiogenic remodeling (Dickson et al., 1995; Oshima et al.,
1996; Lawler et al., 1998; Pepper, 1997). Activin receptor-
like kinase 1 (Alk1), a TGFb and activin-binding receptor,
endoglin (Eng), a TGFb superfamily coreceptor and Smad5
are three such genes that are required for normal angiogen-
esis. Vessels in Alk1, Eng or Smad5 null mutant animals are
fragile, hemorrhagic and dilated. Expression levels of extra-
cellular matrix remodeling enzymes are abnormal, and
recruitment of vascular smooth muscle cells (VSMC) to the
© 2001 Elsevier Science. Avascular endothelium is defective (Chang et al., 1999; Li et
al., 1999; Oh et al., 2000; Pepper, 1997; Urness et al., 2000;
Yang et al., 1999). In addition Alk1-deficient mice develop
arteriovenous malformations (AVMs) that are characterized
by shunting between the arterial and venous circulations,
and an inability to establish molecular and morphological
distinctions between arteries and veins (Urness et al., 2000).
These phenotypes resemble those observed in human pa-
tients suffering from hereditary hemorrhagic telangiectasia
(HHT), a life-threatening condition linked to haploinsuffi-
ciency of ALK1 or ENG (Shovlin and Letarte, 1999).
Emerging models suggest that primary vascular functions
of TGFb signaling are to promote VSMC recruitment and
subsequently VSMC differentiation, and to inhibit endothe-
lial proliferation via VSMC-endothelial interactions. How-
ever, both TGFb superfamily and non-TGFb superfamily
(e.g., angiopoietins) signaling mutants have disrupted
VSMC-endothelial interactions that are consistently asso-
ciated with vessel dilation, fragility and hemorrhage (Puri et
al., 1995; Sato et al., 1995; Suri et al., 1996; Vikkula et al.,
1996). Thus, it is not clear if the direct consequences of
reduced TGFb signaling are loss of VSMCs, vessel dilation,
and impaired vessel integrity, or if these phenotypes might
be secondary to other failed TGFb-dependent functions
(Folkman and D’Amore, 1996; Li et al., 1999; Oh et al.,
2000).
TGFb superfamily signaling is attenuated through a dis-
tinct cohort of negative Smad proteins, one of which is
Smad7 (Afrakhte et al., 1998; Christian and Nakayama,
1999; Hayashi et al., 1997; Itoh et al., 1998; Massague, 1998;
Massague and Chen, 2000; Nakao et al., 1997; Nakayama et
al., 1998a; Nakayama et al., 1998b; Topper et al., 1997;
Tsuneizumi et al., 1997). Smad7 blocks signaling by ligands
of the TGFb, activin and BMP families. Since Smad7
expression is upregulated in response to these signals, it
likely acts as a negative feedback regulator of this system
(Afrakhte et al., 1998; Bhushan et al., 1998; Casellas and
Brivanlou, 1998; Ebisawa et al., 2001; Ishisaki et al., 1998;
Ishisaki et al., 1999; Itoh et al., 1998; Kavsak et al., 2000;
Massague, 1998; Massague and Chen, 2000; Miyazono,
2000; Nakao et al., 1997; Nakayama et al., 2001). In the
vasculature, Smad7 is normally expressed in endothelial
cells of developing and mature vessels, and can be induced
by vascular flow shear stress as well as TGFb signals
(Topper et al., 1997; Zwijsen et al., 2000). During develop-
ment Smad7 is more highly expressed in endothelial cells of
larger blood vessels, perhaps because of their exposure to
greater blood flow (Zwijsen et al., 2000).
Since Smad7 broadly inhibits TGFb superfamily signal-
ing, we hypothesized that misexpressing Smad7 would
allow us to generate additional insights into vascular devel-
opment than are provided by manipulation of more
pathway-specific TGFb superfamily signaling components.
Here we show that misexpression of Smad7 during angio-
ll rights reserved.
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duces dilated vessels, as well as severe vascular malforma-
tions including arteriovenous shunts reminiscent of AVMs.
These phenotypes can be prevented by concomitant activa-
tion of the intracellular BMP signaling pathway. Smad7-
infected vessels are not hemorrhagic, enlarge independently
of VSMCs and do not have defects in VSMC recruitment.
Thus, our results suggest that the principle role of TGFb
superfamily signals during early embryonic angiogenesis
and vascular remodeling is to regulate vessel caliber and
connectivity through the Smad1/Smad5/Smad8 intracellu-
lar pathway. They also suggest that VSMCs do not control
vascular size or integrity in early development.
MATERIALS AND METHODS
Embryology
Fertile White Leghorn chick eggs (SPAFAS) were incubated at
38°C in a humidified, forced air incubator. Experimental manipu-
lations were performed from HH st15 to HH st21 and embryos were
harvested through 72 h postmanipulation (Hamburger and Hamil-
ton, 1951).
The vasculature was visualized either by India ink (1:2 v/v
dilution in Ringer’s saline) or fluorescein-conjugated Ricinus lectin
(Vector labs; 1:5 v/v dilution in Ringer’s saline) injection into the
vitelline vein (Thurston et al., 1996). India ink injected embryos
were fixed immediately in 5% (w/v) trichloroacetic acid, dehy-
drated in ethanol and cleared in methyl salicylate. Lectin injected
embryos were fixed in Dents fix (20% DMSO in methanol) after 10
min incubation at room temperature, dehydrated, and cleared in
TABLE 1
Effects of RCAS Virus-Mediated Gene Misexpression on Limb Ves
Virus
Time
postinfection
(hours) N
Wide
SCA
only
Wide
PMV
only
Smad7 24 20 4 10
48 28 8 2
72 27 1 5
Noggin 24 14 — —
48 7 — —
72 6 — —
BMPR IbDN 24 3 — —
48 3 — —
72 4 — —
GFP 24 3 — —
48 6 — —
72 6 — —
Note. Numbers and types of vascular defects obtained following R
N–number; SCA–subclavian artery; PMV–posterior marginal vein;benzyl alcohol:benzyl benzoate (1:2 v/v; BABB).
© 2001 Elsevier Science. AVirology
An RCAS BP(B)Smad7 virus (Smad7 virus) was constructed by
subcloning the open reading frame of the Xenopus Smad7 gene
(initially called xSmad8) into the RCAS BP(B) retroviral vector via
a pSlax13 shuttle vector intermediate (Logan and Tabin, 1998;
Nakayama et al., 1998b; Souchelnytskyi et al., 1998). The RCAS
BP(A)noggin, RCAS BP(A)BMPR IaCA, RCAS BP(A)BMPR IbDN,
RCAS BP(A)BMPR IbCA, RCAS BP(A)GFP and RCAS BP(B)GFP
viruses were described previously (Capdevila and Johnson, 1998;
Logan et al., 1998; Zou et al., 1997). Concentrated virus stocks
were generated using standard procedures, and all stocks used had
titers of at least 5 3 108 infectious units/ml (Logan and Tabin,
1998).
To target the head, the brain ventricles of HH st15 embryos were
filled with viral supernatant. For single virus limb infections, virus
was injected into HH st17 through st21 wing buds. Injections were
targeted such that either the entire limb or specific subregions were
infected with virus. For double virus limb infections, equal vol-
umes of an A coat virus and the Smad7 B coat virus were mixed and
injected using the same procedure as for single virus injections. In
each experiment positive control Smad7 infections were performed
in parallel. When phenotypic suppression was observed, efficient
infection of both viruses was confirmed using a subset of the
injected embryos. Targeting was monitored by nonradioactive
whole mount in situ hybridization using either a pan-retroviral or
an insert-specific in situ probe (Riddle et al., 1993). Virus distribu-
tion in tissue sections was determined by immunostaining with
the anti p19gag monoclonal antibody 3C2 (Potts et al., 1987).
Immunohistochemistry
Tissue for section immunocytochemistry was fixed in 4% para-
Wide
SCA 1 PMV
only
AVS
(with wide
SCA 1 PMV)
Distal VS
and wide
PMV
No
effect
2 — — 4
4 10 2 2
3 9 9 —
— — — 14
— — — 7
— — — 6
— — — 3
— — — 3
— — — 4
— — — 3
— — — 6
— — — 6
virus infection between HH s17–20, harvested at indicated times.
–arterio-venous shunt; VS–intervenous shunt.sels
CASformaldehyde in PBS and either dehydrated through 30% sucrose
ll rights reserved.
and posterior marginal vein (PMV; blue arrowhead) that have
merged (black asterisk). C-L: India ink-stained limb vasculature. C,
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© 2001 Elsevier Science. Afor cryosectioning or graded alcohols for paraffin embedding. Cryo-
sections were cut at 12 mm and paraffin sections at 8 mm for use in
immunocytochemistry using standard procedures. For virus detec-
tion 3C2 hybridoma supernatant was used at 1:15 dilution. Murine
monoclonal anti-smooth muscle alpha actin, clone 1A4 (Sigma)
was used at 1:850. Cy3-conjugated goat anti-mouse IgG secondary
antibody (Jackson ImmunoResearch, West Grove, PA, USA) was
used at 1:1000.
Embryos were processed for whole mount antibody staining as
described by Kardon (1998). Briefly, embryos were fixed overnight
in Dents fix then placed in Dents bleach (1:2 v/v; 30% H2O2: Dents
Fix) overnight. Embryos were rinsed in PBS, blocked in 5% sheep
serum: 20% DMSO in PBS then stained overnight with anti-
smooth muscle alpha actin antibody (1A4; 1:1000). Embryos were
washed in PBS, stained overnight with Cy3 goat anti-mouse IgG
(1:1000), washed in PBS, dehydrated, cleared in BABB and photo-
graphed using a Nikon Eclipse 800 fluorescence photomicroscope
or a Biorad MRC 500 confocal microscope.
Transmission Electron Microscopy
At various times following Smad7 virus infection, limbs were
fixed at 4°C for 2.5 h in a solution of 2.5% paraformaldehyde: 2%
gluteraldehyde in 0.1M phosphate buffer (PB) (Fallon and Kelley,
1977). Following rinsing in PB, they were processed and epoxy resin
embedded for electron microscopy as described (Fallon and Kelley,
1977). 10mm sections were cut with a glass knife until the correct
location was attained and then 80 nm sections collected and
viewed with a JEOL 1200EX transmission electron microscope.
Endothelial cells lining the subclavian artery of Smad7 virus-
infected and control limbs were identified by location and mor-
phology. Endothelial cell counts were performed on directly visu-
alized TEM images, while interendothelial junctions were assessed
and counted on composite TEM micrographs.
E, G, I, K: Control limbs; D, F, H, J: Smad7 virus-infected limbs; L:
Noggin virus-infected limb. At 24 h postinfection, (D) SCA and
PMV are enlarged relative to control vessels (C), but lack obvious
intervascular shunts (SCA and PMV width demarcated by red or
blue brackets respectively). At 48 h postinfection (F) massively
enlarged subclavian artery and posterior marginal vein are con-
nected via a shunt in the central region of the limb, and are
significantly closer than in control limb (E). In proximal, anterior
and distal mesenchyme enlarged but tortuous looking vessels are
evident (F; black arrowhead). Abnormal avascular spaces are also
visible between distal blood vessels (F; green arrowhead). (H) A
higher magnification view of (F) shows the enlarged SCA, enlarged
PMV and multiple intervascular shunts between the SCA and PMV
(black asterisks). (J) Smad7 virus infected hand plate at HH st24
exhibiting massively enlarged PMV and vascular shunts between
the posterior marginal and interdigital veins. Also note shunting
between the PMV and interdigital vein (blue asterisk). (K) Noggin
virus-infected limb at HH st18 fixed after 72 h has truncated,
widened limb, with normal vasculature and no enlarged bloodFIG. 1. Ectopic Smad7 expression induces vascular defects in the
limb. Right forelimb infected throughout limb mesenchyme at HH
st17, 24–72 h postinfection. A-B: Live view of control (A) and
Smad7 virus-infected (B) limbs 48 h postinfection, showing large
volume of blood in enlarged subclavian artery (SCA; red arrowhead)vessels or visible shunts. Scale bars: 500 mm.
ll rights reserved.
503Smad7 Misexpression in Chick VasculatureFIG. 2. Smad7 virus infection causes substantial dilation of subclavian artery and posterior marginal vein. Transverse sections through
distal (A-B) or proximal region (C-D) of control or HH st17 Smad7 virus-infected limb. A-B: Eight micrometers hematoxylin counterstained
sections, 48 h postinfection. Subclavian artery (SCA) and posterior marginal vein (PMV) are enlarged and closer in Smad7 virus-infected (B)
limb than control limb (A). The control SCA is very small due to distal location of the limb section, and was traced through adjacent
proximal sections, while in the infected limb almost all of the blood vessels are enlarged. In addition the SCA appears to be merging with
many adjacent vessels. C-D: Ten micrometers osmium tetroxide counterstained sections, 72 h postinfection. In the control limb (C) the
SCA is located between the radial and ulnar cartilage anlagen. The SCA and PMV are displaced towards one another in the Smad7
virus-infected limb (D), and are enormously enlarged and might be fusing into an arterio-venous malformation (asterisk). Scale bars: 200 mm.
head (E) has enlarged vessels and changed vascular branching patterns relative to the control head (D) (black arrowhead). Scale bars: 500 mm.
504 Vargesson and LauferFIG. 3. Vascular defects induced by Smad7 are prevented by co-injection of constitutively active BMPR Ib. A-D: India ink-labeled blood
vessels of limbs fixed 72 h after virus injection at HH st20. A: Uninfected limb, contralateral to limb in panel B. Position and width of SCA
(red arrowhead and red bracket) and PMV (blue arrowhead and blue bracket) as indicated; B: Smad7(B) virus-infected limb. Note widened
SCA and PMV and vascular shunt (black asterisk); C: Limb following coinjection of Smad7(B) virus and GFP(A) virus. Note the widened
PMV, SCA and vascular shunt, and the similarity in phenotype severity to Smad7 virus-infection; D: Limb following injection of Smad7(B)
and BMPR IbCA(A). Note no widened vessels, no connectivity defects and apparently normal vascular architecture, however, the distal partFIG. 4. Smad7 induces dilated and merged arteries in the developing head. A-E India ink-labeled blood vessels of embryos infected in brain
ventricles with Smad7 virus. A-C: Dorsal view through the hindbrain A) Uninfected control head. The major arteries–the right and left
internal carotid arteries (ICA; arrowheads) are separate and the basilar artery (BA; arrow) is small and has asymmetric posterior
communicating arterial connections (P. Comm; arrow) to the ICAs. B-C: Ventricular infection at HH st15, 72 h postinfection. (B) The BA
and ICAs are significantly enlarged, and the ICAs have merged (white arrowhead). (C) The BA and ICAs are enlarged and the ICAs are not
fused. However, the left ICA has an intra-arterial shunt (white arrowhead) and the branching pattern of the left ICA at the cranial ramus
of the Circle of Willis is abnormal (black arrowhead). Furthermore, the right posterior communicating artery (white asterisk) is abnormally
dilated. D-E: Lateral views of vasculature supplying midbrain, ventricular infection at HH st18, 48 h postinfection. Smad7 virus-infectedof the limb is truncated. The inset box shows higher magnification image of proximal limb indicating SCA is not enlarged. SCA–subclavian
artery; PMV–posterior marginal vein. Scale bars: 500 mm A-D, 250 mm inset.
© 2001 Elsevier Science. All rights reserved.
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Digital images of 8 mm transverse sections were collected, and
blood vessel dimensions measured using NIH Image 1.61 software.
For each Smad7 virus-infected limb a proximal section that contained
the largest vessels near the entry point of the subclavian artery into
the limb was chosen, and area and perimeter of the subclavian artery
and posterior marginal vein were measured. Vessels in an equiva-
lently positioned section from the contralateral control limb were also
measured. A minimum of six Smad7 virus-infected and control limbs
TABLE 2
Coexpression of Constitutively Active BMP Receptors Prevents th
Virus
Time
postinfection
(hours) N
Wide
SCA
only
Wide
PMV
only
Smad7(B) 24 6 1 3
48 6 1 1
72 7 — 3
Smad7(B) 1 BMPR IaCA(A)a 24 5 — —
48 5 — 2
72 7 — 2
Smad7(B) 1 BMPR IbCA(A) 24 4 — —
48 5 — —
72 8 — 3
Smad7(B 1 BMPR IbDN(A) 24 3 — —
48 3 1 —
72 5 — 1
Smad7(B) 1 GFP(A) 24 4 1 1
48 4 — 2
72 6 1 1
Note. Numbers and types of vascular defects obtained followin
combinations as indicated. Embryos were infected between HH s18
presented here are also incorporated into Table 1. Abbreviations a
a Vascular phenotypes observed with this virus combination wewere analysed at each time point examined.
and intact basement membrane (white arrowhead). Red blood cells are
© 2001 Elsevier Science. ARESULTS
Ectopic Smad7 Expression Causes Defects in Limb
Vasculature
A replication-competent RCAS avian retrovirus that ex-
presses the Xenopus Smad7 gene was constructed to inves-
tigate the consequences of blocking TGFb superfamily
ad7-Induced Vascular Defects
Wide
CA 1 PMV
only
AVS
(with wide
SCA 1 PMV)
Distal VS
and wide
PMV
Limb
truncation
No
effect
— — — — 2
— 2 — — 2
— 2 1 1 —
— — — 1 4
1 1 — 1 —
1 2 — 2 —
— — — 2 2
— — — 5 —
— — — 5 —
1 — — — 2
— 1 — 1 —
— 4 — — —
— — — — 2
— 1 — — 1
— 2 1 1 —
AS (B) or simultaneous RCAS (A) and (B) subtype double virus
nd harvested post-infection at indicated times. The Smad7(B) data
able 1.
a milder nature compared to Smad7 virus alone.signaling during avian development. The Xenopus gene wasFIG. 5. Transmission electron micrographs showing intact vessels and presence of intercellular junctions. A-B: TEM micrograph of
subclavian artery, HH st17 limb infection, 72 h postinfection. Endothelial cells lining the subclavian artery of control (A) and Smad7
virus-infected (B) limbs. In both control and Smad7 virus-infected vessels, endothelial cells are tightly associated and have intact junctions
between endothelial cells (black arrowheads). Moreover the endothelial cells are present as a monolayer and have an apparently continuouse Sm
S
g RCobserved only in the vessel lumen. Scale bar: 1 mm.
ll rights reserved.
506 Vargesson and Lauferused because its activity is well characterized, and so that
exogenous transcripts could be distinguished from those of
the endogenous Smad7 gene (Nakayama et al., 1998b). Limb
primordia were injected with Smad7 virus at HH st17 to
st21 after the onset of angiogenesis, and examined from 24
to 72 h later. Immunostaining for expression of a viral-
specific epitope or whole mount in situ analysis using a
viral-specific probe revealed that both vascular endothe-
lium and surrounding nonvascular tissue are infected with
Smad7 virus (data not shown).
Infection by this protocol causes striking vascular de-
fects. As early as 24 h postinfection, an apparent pooling of
blood in central and proximal posterior limb regions was
consistently observed in living embryos. By 48 h postinfec-
tion the major vessels, particularly the subclavian artery
and posterior marginal vein, were visibly enlarged and
displaced towards the dorsal limb surface (n .600; Fig. 1A,
B). Despite these gross vascular defects, no edema or inflam-
mation of surrounding tissue was observed.
To visualize the entire vasculature, India ink was
injected into the vitelline vein and the embryos cleared.
Limbs were scored for alterations in vessel size and
connectivity (Table 1). Major vessel enlargement is vis-
ible within 24 h postinfection (Fig. 1C, D), and by 48 h the
subclavian artery and posterior marginal vein are dilated
into huge tube-like structures, and can be displaced
towards one another (Figs. 1E, F). Examination of vessels
in sectioned limb tissue confirms that vessel caliber is
substantially increased (Fig. 2). The subclavian artery and
posterior marginal vein can be either independently or
simultaneously affected. In addition, smaller vessel orga-
nization in proximal and distal regions of the limb is
disrupted, and some of these vessels are enlarged and
appear tortuous (Fig. 1F). There are also abnormally wide
avascular spaces separating the vessels, suggestive of
reduced angiogenic remodeling (Fig. 1F). The indepen-
dence of the vascular dilation phenotypes was confirmed
by targeting virus in some embryos to either the central
or posterior limb tissue. In these instances only the major
vessel in the targeted area is dilated (not shown).
Vascular shunts that bypass the capillary beds between
the arterial and venous circulations are also often observed.
They are particularly evident from 48 h postinfection be-
tween the subclavian artery and posterior marginal vein in
central or distal regions of the limb (Figs. 1F, H and 2C, D).
Intervenous shunts also form distally between the posterior
marginal vein and interdigital veins. These venous shunts
can form either in addition to or independently of arterio-
venous shunts (Fig. 1H, J). While vessel enlargement can
occur in the absence of obvious vascular shunting, we do
not observe shunting in the absence of enlarged vessels.
Furthermore there is a general progression of vascular
abnormalities from dilation to simple and then complex
shunting with time (Fig. 1, Table 1).
© 2001 Elsevier Science. AThe Effects of Smad7 Misexpression Are Not
Phenocopied by BMP Signaling Antagonists
To assess whether these vascular defects are specific to
Smad7 misexpression, we infected limb tissue with several
other RCAS viruses. Infection with an RCAS-GFP virus did
not cause any reproducible vascular malformations, indi-
cating that RCAS virus infection alone does not perturb
vascular development. To test whether antagonism of BMP
signaling can cause similar vascular defects, we misex-
pressed the BMP binding protein noggin or a dominant
negative form of BMPR Ib (BMPR IbDN) using a similar
retroviral infection strategy. Neither virus caused signifi-
cant vascular defects (Fig. 1K and Table 1).
While they did not all cause vascular defects, the noggin,
BMPR IbDN and Smad7 viruses did induce similar defects in
other aspects of limb development. The noggin virus-
infected limbs are truncated, have a thickened AER, de-
creased expression of Shh pathway components, reduced
programmed cell death and do not develop cartilage con-
densations. The BMPR IbDN virus caused similarly trun-
cated and broadened limbs (data not shown). These obser-
vations are consistent with previous reports using these
viruses (Zou et al., 1997; Capdevila and Johnson, 1998;
Pizette and Niswander, 1999). Smad7 virus-infected limbs
exhibit phenotypes very similar to those caused by noggin
misexpression, and will be described in detail elsewhere
(data not shown; manuscript in preparation). Taken to-
gether these data suggest that while Smad7 can effectively
block BMP signaling in the limb, the additional vascular
defects are not due to blocking BMP signals.
Intracellular BMP Pathway Activation Prevents
Smad7-Induced Vascular Defects
Our data suggest that antagonizing TGFb superfamily
signaling causes severe vascular defects. If this is the case,
then simultaneous intracellular activation of a positive
Smad signaling pathway might prevent or reduce the
Smad7-induced vascular phenotypes. To test this hypoth-
esis we used a viral coinfection strategy. The RCAS Smad7
virus has a B subtype envelope, and thus A subtype viruses
can superinfect Smad7(B) virus-infected cells. We combined
Smad7(B) virus with various RCAS(A) subtype viruses en-
coding constitutively active (CA) or dominant negative
BMP receptors and infected limb buds with the multivirus
cocktails.
Coinfection of Smad7(B) and BMPR IbCA(A) viruses re-
sulted in essentially normal vessel morphology, even 72 h
after infection. Neither the subclavian artery nor the pos-
terior marginal vein is significantly enlarged, and intervas-
cular shunting is absent (Fig. 3; Table 2). Some distal
truncation of the limb mesenchyme is observed. This is
similar to the effects caused by weak infection with the
BMPR IbCA(A) virus alone (Zou et al., 1997). A similar result
was observed when BMPR IaCA(A) was introduced in com-
ll rights reserved.
507Smad7 Misexpression in Chick Vasculaturebination with Smad7(B) (Table 2). However, in this case
mild vessel dilation and shunt formation is occasionally
observed. Infection with either of the constitutively active
BMPR viruses alone leads to severe defects in limb out-
growth and tissue differentiation (data not shown; Zou et
al., 1997). Thus, their effects on vascular development
could not be easily assessed. Smad7(B) virus in combination
with either BMPR IbDN(A) or GFP(A) virus resulted in
vascular defects similar in frequency and severity to infec-
tion with Smad7(B) virus alone (Table 2). Suppression of the
Smad7 virus induced phenotype is thus specific to simulta-
neous activation of the intracellular BMP signaling path-
way, and is not attributable to dilution or competition by
the (A) coat viruses.
Smad7 Infection Causes Vascular Malformations
in the Developing Brain
To ascertain if Smad7 misexpression could cause similar
vascular abnormalities in other regions of the embryo, the
developing brain ventricles were injected with Smad7 virus
at HH st15. Only angiogenesis and angiogenic remodeling
events are occurring at this stage of cranial vessel develop-
ment (Hughes, 1934; Pardanaud et al., 1987; Coffin and
Poole, 1988; Pardanaud et al., 1989; Poole and Coffin, 1989;
Risau, 1997). As in the limb, vascular defects are observed
as early as 24 h postinfection (Fig. 4). In the majority of
cases the basilar and internal carotid arteries are dilated
(Table 3). The right and left internal carotid arteries are also
frequently displaced medially towards each other, and by
48 h postinfection can merge abnormally, forming arterial
anastomoses and premature connections between the left
and right cranial circulations (Fig. 4A-D; Table 3). In addi-
tion intra-arterial shunts fusing back to the same vessel are
observed (Fig. 4D; Table 3). The major vascular branches
supplying blood to the midbrain are also enlarged, with
reduced branch formation and apparent intravascular
shunting (n 5 4/4; Fig. 4E,F).
Thus, Smad7 misexpression causes vascular dilation,
fusion, and shunt formation in multiple regions of the
embryo. Moreover, appropriate physical separation between
the major vessels is not maintained, since the relative
positions of the right and left internal carotid arteries in the
head and the subclavian artery and posterior marginal vein
in the limb are frequently perturbed (Figs. 1F; 4B,C).
Smad7 Virus-Infected Blood Vessels Are Intact and
Are Not Hemorrhagic
In mice mutant for TGFb ligands or receptors, as well as
in human HHT patients, blood vessels lack structural
integrity and hemorrhage blood into the surrounding mes-
enchyme (Dickson et al., 1995; Oshima et al., 1996; Shovlin
and Letarte, 1999). Therefore, we asked whether Smad7
misexpression causes similar gross defects in vessel integ-
rity. India ink or fluorescently labelled Ricinus lectin was
© 2001 Elsevier Science. Ainjected into the embryonic circulation of Smad7 virus-
infected embryos (Thurston et al., 1996). Neither stain
penetrated beyond the vascular lumen when examined in
whole mount or sectioned limb tissue (Fig. 1 and data not
shown). In addition no signs of hemorrhage were observed
in sectioned tissue (Fig. 2).
We also examined vessel integrity by transmission elec-
tron microscopy (TEM). In electron micrographs blood cells
are observed only inside the vessels, consistent with the ink
and lectin injection results (Fig. 5). Furthermore interendo-
thelial cell junctions, which prevent the passage of blood
cells outside the endothelium and help maintain the integ-
rity of the endothelial layer, are visible between all endo-
thelial cells lining the dilated infected vessels (166 endo-
thelial cell junctions examining in infected tissue vs. 56 in
control tissue; Fig. 5A, B). In addition the basement mem-
brane underlying the endothelial cells appears intact (Fig.
5A, B). Thus, from analysis of several independent criteria,
vessel integrity is not grossly compromised by Smad7
misexpression, despite severe defects in vessel size and
connectivity.
Endothelial Cell Morphology Lining Smad7
Virus-Infected Vessels Appears Normal
To determine if increased vessel size correlates with
changes in endothelial layer morphology, we examined
Smad7 virus-infected vessels by TEM and light microscopy.
In addition to the presence of endothelial cell junctions and
a normal basement membrane, the endothelial cells have
typical endothelial morphology, with a centrally located
nucleus, are of normal size and are present in a monolayer
(Fig. 5).
Blood vessel size was measured in limbs harvested at
various times following Smad7 virus infection. Limbs were
sectioned transversely across the major vessel axis, and
perimeters and cross-sectional areas of the subclavian ar-
tery and posterior marginal vein determined (Fig. 6A, B).
Both perimeter and area of infected vessels are larger than
control limbs from 18 h postinfection, and continue to
increase through 72 h postinfection, the latest time point
examined (Fig. 6A, B). At this time mean perimeter is
increased approximately 2.8-fold and mean vessel area is
increased approximately sevenfold relative to control ves-
sels.
The apparently normal endothelial cell morphology com-
bined with the enlarged vessel size suggested that affected
vessels contain more endothelial cells. Therefore, we
counted endothelial cells in TEM micrographs of subcla-
vian arteries of Smad7 virus-infected and control limbs.
Smad7 virus-infected vessels contain approximately 2.5-
fold more endothelial cells than control vessels at 72 h
postinfection (87 6 4.3 cells per section[mean 6 SEM] in
infected tissue, n 5 9; vs. 34 6 1.3 cells in control tissue,
n 5 8). Electron micrographs were used as we lack a reliable
immunochemical marker of chick endothelial cells that
ll rights reserved.
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nary studies we have also counted endothelial cells identi-
fied in paraffin embedded tissue sections based on cell
morphology, and find an increase in cell number consistent
with the increases in perimeter from 24 through 72 h
postinfection (data not shown). As the mean changes in
perimeter length and endothelial cell number are similar,
the endothelial cell density in Smad7 virus-infected limbs
FIG. 6. Changes in vessel size following Smad7 virus infection.
posterior marginal veins of Smad7 virus-infected and control li
PMV–posterior marginal vein. Values shown are mean 6 SEM. Nis essentially unaffected. Taken together the cell density,
© 2001 Elsevier Science. Avessel morphology and vascular integrity data suggest that
Smad7 misexpression causes gross dilation of otherwise
normal endothelial tubes.
Vessel Widening Is Independent of Vascular
Smooth Muscle
In mouse mutants as well as human diseases with defects
eters (A) and cross-sectional areas (B) of subclavian arteries and
from 24 to 72 h after virus infection. SCA–subclavian artery;
for each value.in TGFb superfamily signaling that display an enlarged and
ll rights reserved.
509Smad7 Misexpression in Chick VasculatureFIG. 7. Smad7 misexpression does not affect vascular smooth muscle. Immunofluorescent staining of smooth muscle alpha actin (SMA)
expression following Smad7 virus-infection of embryonic chick limbs and heads. A-B: Confocal images of control (A) and Smad7
virus-infected (B) whole mount limbs infected at HH st17, 72 h postinfection. SMA expression is detected surrounding both normal (A) and
dilated (B) subclavian arteries (SCA) and just beyond the branchpoint of the ulnar and radial arteries. The distal extent of SMA
immunoreactivity is shown. Staining also extends proximally to the base of the limb, but is out of the focal plane of the image. Some
immunoreactivity is also seen in the dorsal and ventral muscle masses (MM). Proximal is to left in both images. C-D: Transverse sections
of limb tissue at entry point of SCA in limb. Control (C) and Smad7 virus-infected (D) limb sections, infected at HH st17, 48 h postinfection.
Both control and enlarged, infected SCAs are surrounded by a similar extent of SMA immunoreactivity, and no other vessels stain positive
for SMA. The posterior marginal vein (PMV) in (D) is also enlarged. Neither affected nor control PMVs show any SMA staining. E-F:
Confocal images of whole mount control (E) and Smad7 virus-infected (F) heads, infected at HH st18, 48 h postinfection. SMA staining
covers the vascular branch supplying blood to the developing midbrain (asterisk), as well as the capillaries covering the midbrain in both
images. In the virus-infected head the vascular branch is widened (asterisk), has a less complex branching pattern, and has an intravascular
shunt (arrow). Scale bars: 200 mm.
© 2001 Elsevier Science. All rights reserved.
510 Vargesson and Lauferhemorrhagic vessel phenotype there is a loss or disorgani-
sation of vascular smooth muscle cells associated with the
affected vessels (Chang et al., 1999; Dickson et al., 1995; Li
et al., 1999; Oh et al., 2000; Shovlin and Letarte, 1999;
Urness et al., 2000; Yang et al., 1999). Thus, TGFb super-
family signaling might be required for VSMC recruitment
and maintenance, and VSMC-endothelium interactions
might be required to maintain vascular integrity (Folkman
and D’Amore, 1996).
To determine whether the vascular phenotypes correlate
with changes in recruitment or loss of VSMC, the expres-
sion of smooth muscle alpha actin, a marker of differenti-
ated VSMC, was examined by whole mount and section
immunohistochemistry in Smad7 virus-infected and con-
trol limbs from HH st20 through HH st30 (Fig. 7). In control
HH st20 limbs, smooth muscle alpha actin expression is
detected only in tissue surrounding the proximal region of
the subclavian artery, and is absent from the remaining
limb vasculature. As limb development proceeds, this ex-
pression is detected progressively more distally surrounding
the subclavian artery, and its major branches, the radial and
ulnar arteries (Fig. 7A). At the latest developmental stages
examined, some expression is also observed in association
with secondary arterial branches. However, the majority of
vessels in the limb, including the posterior marginal vein,
are devoid of differentiated VSMCs from HH st20 through
HH st30 (Fig. 7A, C). Thus, unlike in many other regions of
the embryo, there is a prolonged time period between the
formation of the limb vasculature and its association with
differentiated smooth muscle cells. Since Smad7 virus
infection causes posterior marginal vein dilation without
gross loss of integrity prior to HH st30, differentiated
VSMCs must not be required to maintain either the caliber
or integrity of these vessels. However, VSMC precursors
that do not yet express smooth muscle alpha actin might be
associated with these vessels.
Examination of smooth muscle alpha actin immunoreac-
tivity in Smad7 virus-infected limbs reveals little, if any,
TABLE 3
Effects of RCAS-Smad7 Virus Infection on Hindbrain Vessels
Time
(hours)
Phenotype
ICA dilated ICA merged ICA shunts BA dilated
24 1/3 0/3 0/3 0/3
48 10/11 6/11 0/11 10/11
72 9/11 8/11 2/11 9/11
Total 20/25 80% 14/25 56% 2/2 58% 19/25 76%
Note. Number and frequency (%) of enlarged vessels and vascular
malformations observed following Smad7 virus-infection of brain
ventricles harvested at various times after HH s15–17 infection.
ICA–Internal carotid artery; BA–Basilar artery.alteration compared to control limb staining patterns, de-
© 2001 Elsevier Science. Aspite the dramatic effects of Smad7 misexpression on vessel
caliber. In Smad7 virus-infected limbs the enlarged subcla-
vian artery is surrounded by VSMCs, and the spatial distri-
bution and proximo-distal temporal progression of staining
appear normal (Fig. 7B, D). In normal mature vessels there is
a positive correlation between arterial caliber and the
thickness of the surrounding smooth muscle cell layer.
Thus, an enlarged VSMC layer surrounding the dilated
vessels might be anticipated. However, transversely sec-
tioned vessels show no significant difference in the thick-
ness of the smooth muscle alpha actin immunoreactive cell
layer around the subclavian arteries of Smad7 virus-infected
or control limbs (Fig. 7A–D). The lack of change might
reflect either a specific effect of Smad7 misexpression, or
the early developmental stage of the vasculature.
We also examined vascular smooth muscle cell distribu-
tion associated with the lateral midbrain vessels of Smad7
virus-infected heads (Fig. 4E, F). Whole mount immuno-
staining for smooth muscle alpha actin in normal embryos
reveals that unlike in the limb, even small cranial capillar-
ies possess a smooth muscle coating (Fig. 7E). Smad7 virus
infection of developing brain ventricles at HH st15 causes
dilation of the main vascular branches supplying blood to
the midbrain within 48 h, as well as intra-arterial shunting
and a reduction in the complexity of the secondary branch-
ing patterns (Figs. 4E, F; 7F). In these heads all vessels also
possess an apparently normal smooth muscle coat (Fig. 7F).
Taken together these results suggest that the increase in
vessel caliber caused by Smad7 misexpression is indepen-
dent of VSMC recruitment, as we observe vessel dilation
both in the absence and presence of VSMCs. In addition
they indicate that VSMC recruitment, differentiation and
maintenance are not blocked by Smad7 misexpression.
DISCUSSION
Our data demonstrate that Smad7 misexpression has
profound effects on vascular development. We have used a
replication competent retrovirus to misexpress Smad7 in
the developing limb and head during periods of angiogen-
esis, subsequent to initial formation of the embryonic
vasculature. We observe significant and rapid vessel dila-
tion, but no loss of vessel integrity or alteration of the
endothelial cell layer except for an increase in endothelial
cell number commensurate with the changes in vessel size.
Smad7 misexpression also causes inappropriate merging of
vessels and gross vascular malformations, including arterio-
venous and intravascular shunting. Interestingly Smad7
misexpression appears to only mildly delay angiogenic
vessel branching. We observe no consistent correlation
between vascular smooth muscle cells and the Smad7
vascular phenotype. The vascular phenotypes occur regard-
less of differentiated VSMC association with affected ves-
sels, and VSMC recruitment, differentiation and mainte-
nance are unaffected by Smad7 misexpression.
ll rights reserved.
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Misexpression
Our results raise several interesting questions about the
identity of the signals, their signal transduction pathways,
and the cellular targets upon which Smad7 might be acting.
Smad7 can block signaling by BMP, activin, and TGFb
family ligands (Nakao et al., 1997; Bhushan et al., 1998;
Casellas and Brivanlou, 1998; Ishisaki et al., 1998; Ishisaki
et al., 1999; Massague, 1998). Multiple BMP family mem-
bers are expressed in the developing limb and head, while
both TGFb and activin family members are expressed in
association with the vasculature (Hogan, 1996; Matzuk et
al., 1995a,b; Pepper, 1997). Thus, Smad7 might be blocking
signals from any of the major TGFb superfamily protein
families. However, the combination of our gene misexpres-
sion experiments and previously described gene knockout
experiments suggest that some of these signals are less
likely targets than others. Misexpression of neither noggin
nor a dominant negative BMP receptor caused Smad7-like
vascular phenotypes. They both caused other limb develop-
mental defects that are consistent with previous reports,
indicating that these reagents are active in our experiments
(Capdevila and Johnson, 1998; Pizette and Niswander, 1999;
Zou et al., 1997). In vitro binding studies and in vivo
misexpression studies indicate that noggin blocks a broad
range of BMP family ligands, including BMP2, BMP4, and
BMP7, the primary BMPs expressed in the developing limb
and head (Capdevila and Johnson, 1998; Pizette and
Niswander, 1999; Zimmerman et al., 1996; A. Economides,
Regeneron Corp, personal communication). While activins
are expressed in the developing vasculature, activin null
mice do not display vascular phenotypes (Matzuk et al.,
1995a,b). The ligand expression patterns combined with
gene knockout and viral misexpression phenotypes suggest
that the vascular Smad7 phenotype is not due to inhibition
of BMP or activin signals.
Despite the noggin and BMPR IbDN data suggesting that
BMP-type ligands are not vascular regulators, we observe
that constitutive activation of BMP receptor intracellular
signaling pathways is sufficient to inhibit the formation of
Smad7-induced vascular defects. This result suggests that a
non-BMP ligand (or ligands) acts through the intracellular
side of the BMP pathway, perhaps through activation of a
different receptor that impinges on the same signal trans-
duction pathway. BMPR Ia and BMPR Ib activate the
Smad1/Smad5/Smad8 cohort of positive Smad proteins,
targets that are shared by an activated Alk1 receptor (Eppert
et al., 1996; Hoodless et al., 1996; Massague and Chen,
2000; Oh et al., 2000). However, the functional ligands for
Alk1 are poorly defined; Alk1 can bind TGFb protein, but
has not been shown to be activated by it (Chen and
Massague, 1999; Oh et al., 2000). Intriguingly, loss of
function Alk1 and Smad5 mutant mice have vascular
phenotypes that are similar to, but distinct from, those we
observe following Smad7 misexpression (Chang et al., 1999;
© 2001 Elsevier Science. AOh et al., 2000; Urness et al., 2000; Yang et al., 1999).
Another possibility is that Smad7 is interfering with a
non-TGFb superfamily type signal, as Smad proteins can
interact with non-TGFb signaling pathways (Casellas and
Brivanlou, 1998; Nagarajan et al., 2000; Ulloa et al., 1999).
However, our activated BMP receptor rescue experiments
strongly suggest that TGFb superfamily signaling is the
functional target.
TGFb proteins are expressed in association with the
developing vasculature and in vitro can have profound
effects on endothelial cell and vascular smooth muscle cell
growth and differentiation, as well as endothelial tube
morphogenesis. TGFb1 in particular is highly expressed by
peripheral endothelial cells and is required for normal
vascular development (Dickson et al., 1995; Gatherer et al.,
1990; Pepper, 1997; Schmid et al., 1991). Thus, TGFb1, or
another unknown but related ligand, or ligand heterodimer
combination, perhaps acting through Alk1 and Smad5, is
the most likely candidate for activating the pathway with
which Smad7 is interfering.
The most likely cell type on which Smad7 is acting is the
endothelial cells. They are the only cells definitively af-
fected by Smad7 misexpression, increasing in number in
association with changes in the vasculature. While Smad7
might affect vascular smooth muscle cells, we observe clear
defects in vessels, such as the posterior marginal vein of the
limb, that have no associated differentiated VSMCs. We
also observe no obvious changes in the recruitment, differ-
entiation or maintenance of the VSMC layer surrounding
affected vessels in the limb or head. While we always
observe infection of the vascular endothelium of dilated
vessels, we can not rule out the possibility that nonvascular
mesenchymal cells are affected, since the replication-
competent RCAS virus infects these cells as well.
Normal Role of Smad7 as a Regulator of Vascular
Caliber
Smad7 is a signaling antagonist that likely normally acts
to attenuate positive TGFb superfamily signals. By express-
ing Smad7 under the control of the RSV LTR of the RCAS
virus, we have decoupled Smad7 expression from its normal
transcriptional regulation. Therefore, the vascular pheno-
types we observe can provide some insights into possible
normal roles of Smad7 and TGFb superfamily signals as
regulators of vascular development.
Our studies suggest a dual role for endogenous Smad7.
Endothelial Smad7 expression can be induced either by
activation of the TGFb superfamily signaling pathway, or
by flow-induced shear stress, and endogenous Smad7 levels
are higher in larger vessels during murine development
(Topper et al., 1997; Zwijsen et al., 2000). Our experiments
indicate that viral Smad7 causes vessel dilation throughout
the noncapillary vasculature, presumably due to increased
Smad7 levels, while constitutive activation of the BMP
signaling pathway counteracts this effect. Thus, TGFb
ll rights reserved.
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might normally function to constrain vessel size, and
compete with feedback-induced Smad7 to establish a
steady-state vascular caliber (Fig. 8). Increased flow during
embryonic growth might be responsible in part for the
higher endogenous Smad7 levels in larger vessels, indepen-
dent of TGFb superfamily signals. This would shift the
balance between TGFb signaling and Smad7, and could in
turn lead to increased vessel size, thus accommodating the
larger circulatory needs of the growing embryo (Fig. 8).
While Smad7 virus-infected blood vessels contain up to
threefold more endothelial cells, the source of these cells is
unclear. The simplest explanation is that endothelial cell
proliferation is increased, consistent with in vitro inhibi-
tion of endothelial cell growth by TGFb (Pepper, 1997).
However, in preliminary studies, we have not been able to
detect significant changes in endothelial cell proliferation
(data not shown). Alternatively, Smad7 might reduce
TGFb-mediated endothelial cell death, lead to the recruit-
ment of additional endothelial cell precursors from the
circulation, or promote transdifferentiation of surrounding
mesenchymal cells (Pepper, 1997; Yamashita et al., 2000).
Other mechanisms by which vessel size might be increased
are by suppressing secondary sprout formation, or by caus-
ing fusion of neighboring vessels. Consistent with this idea,
excess vessel fusion has been reported in Alk1 null mice
(Urness et al., 2000). However, while we do detect increased
avascular regions surrounding enlarged vessels (Figs. 1F, H;
4D, E), this is not always the case, especially in the
midbrain near the dilated internal carotid arteries, where
the surrounding vasculature looks essentially normal
FIG. 8. Model of TGFb regulation of vessel caliber. TGFb
signals received by endothelial cells and transduced via the
positive Smads, Smad1, Smad5, and Smad8, reduce vessel cali-
ber, while signal strength is attenuated by Smad7 through a
negative feedback mechanism. Smad7 can also be independently
induced via a flow-mediated mechanism, thus providing an
additional reduction in TGFb signal strength. If flow is reduced,
vessels constrict, while if flow is increased, vessels dilate. These
changes take place over a long time period relative to pharma-
cological constriction and dilation mediated by the vascular
smooth muscle layer. TGFb in the figure can be representative of
any TGFb superfamily ligand, although the TGFb1 isoform
seems most likely (see text).(Fig. 4A-C).
© 2001 Elsevier Science. AFunction of Vascular Smooth Muscle Cells
in Vascular Development
The relationship between vascular smooth muscle cells,
TGFb superfamily signals and vascular development is
complex, and incompletely resolved. VSMCs are thought to
interact with the vascular endothelium to maintain vascu-
lar integrity, and are also proposed to regulate vessel caliber
by activating TGFb signals to the underlying endothelium,
thus inhibiting endothelial proliferation. Reciprocal TGFb
superfamily signals from the endothelial cells are thought
to be required for recruitment, differentiation and/or main-
tenance of vascular smooth muscle cells during develop-
ment and in adults (Folkman and D’Amore, 1996; Pepper,
1997; Yancopoulos et al., 2000).
Our data indicate that neither vessel caliber nor integrity
necessarily depends on vascular smooth muscle-endothelial
interactions during development, despite their linkage in
some germline mouse mutants (Chang et al., 1999; Li et al.,
1999; Oh et al., 2000; Puri et al., 1995; Sato et al., 1995; Suri
et al., 1996; Urness et al., 2000; Vikkula et al., 1996; Yang
et al., 1999). Following Smad7 virus infection we observe
vascular dilation without any loss of structural integrity
even in the absence of differentiated VSMCs, as seen, for
example, in the posterior marginal vein of the limb. Once
the vascular smooth muscle layer is formed, however, it
might normally constrain vessel caliber through activation
of latent TGFb ligand (Folkman and D’Amore, 1996). If this
is the case, Smad7 misexpression in our experiments would
functionally uncouple these two cell types by preventing
TGFb signal transduction despite ligand activation, thereby
allowing vessel dilation. However, as vascular integrity is
not compromised in dilated vessels that retain a VSMC
coat, then VSMC maintenance of vessel integrity and
VSMC regulation of caliber apparently do not involve a
common signaling system.
Smad7 viral misexpression also dissociates the processes
of vascular smooth muscle cell recruitment, differentiation
and maintenance from TGFb superfamily signaling. During
chick limb development, differentiated VSMCs, as identi-
fied by smooth muscle alpha actin immunoreactivity, are
present initially surrounding only the proximal subclavian
artery and are recruited to additional vessels over time.
Smad7 misexpression does not affect either the mainte-
nance of the VSMC coat, or the recruitment of VSMCs to
more distal regions. Cranial vessels, which develop contem-
poraneously with their VSMC coat, have an apparently
normal VSMC layer despite Smad7-induced dilation. Thus,
Smad7 misexpression, and by inference, reduced TGFb
superfamily signaling, does not interfere with normal
VSMC development.
Comparison with in Vivo Loss of Function Data
HHT patients, as well as endoglin, Alk1 and Smad5 null
mutant mice, each of which is defective in TGFb superfam-
ll rights reserved.
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from those observed following Smad7 misexpression
(Chang et al., 1999; Li et al., 1999; Oh et al., 2000; Shovlin
and Letarte, 1999; Urness et al., 2000; Yang et al., 1999). In
each mutant recruitment or maintenance of the vascular
smooth muscle layer is disrupted and vascular integrity is
significantly compromised, in striking contrast to the ap-
parently normal vascular smooth muscle layer and intact
vessels associated with Smad7 misexpression. Several ex-
planations for these phenotypic differences are worth con-
sidering.
One possibility is that the signaling defect in the germ-
line mutants might be qualitatively different from that
caused by Smad7. The mutations in the endoglin, Alk1 and
Smad5 genes might disrupt a critical balance between the
parallel Smad2/Smad3 and Smad1/Smad5/Smad8 branches
of the TGFb superfamily signaling pathway (Oh et al.,
2000). In contrast Smad7, a broad spectrum signal transduc-
tion antagonist, might interfere with each branch to a
similar degree. Gross pathway imbalance in the mutants
might thus lead to more severe outcomes than an overall
signal blockade. While a distinct possibility, our results
demonstrating that activation of only the BMP receptor side
of the pathway is sufficient to prevent the Smad7-induced
vascular phenotype strongly suggests that balanced path-
way activation is not critical.
Mice lacking Alk1, endoglin or Smad5 function die dur-
ing early angiogenesis, as they suffer from a general disrup-
tion of cardiovascular function (Chang et al., 1999; Li et al.,
1999; Oh et al., 2000; Urness et al., 2000; Yang et al., 1999).
Impaired VSMC recruitment or reduced vascular integrity
in these animals might be secondary to a developmental
delay, or the decline in overall embryonic health. Alterna-
tively, the more severe germline phenotypes might result
from earlier, hidden vasculogenic defects that are un-
masked as development proceeds. Because Smad7 virus
infection is localized within the embryo, and occurs after
establishment of the primary circulation, such secondary
effects might not be observed.
Implications for Etiology of Arterio-Venous
Malformations (AVM)
We observed arterio-venous shunts in the vasculature of
the majority of Smad7 virus-infected limbs. These results
are consistent with previous reports that link the TGFb
superfamily pathway to arterio-venous malformations, and
suggest that Smad7 misexpression is a useful model for
studying AVM formation. In human patients AVMs are
clinically significant vascular structures. Shunting blood
directly between the arterial and venous circulations can
make more distal structures hypoxic, and can disrupt criti-
cal capillary-based functions in organs such as the lungs or
liver (Shovlin and Letarte, 1999). In addition increased
blood volume combined with the loss of vascular resistance
to flow can lead to heart failure (Shovlin and Letarte, 1999).
© 2001 Elsevier Science. ABoth Smad7 gain of function and germline Alk1 loss of
function can cause AVM formation, however these models
differ as the Smad7-induced AVMs form substantially after
the onset of angiogenesis.
AVMs are characterized by anomolous arterio-venous
connections and dilated vessels feeding into and out of the
shunt. These phenotypes might arise independently, or via
a temporally linked mechanism. In Alk1 null mutant mice
shunt formation is the earliest visible vascular defect,
occurring prior to vessel dilation (Urness et al., 2000). In
contrast in HHT patients, arteriole and venule dilation is
observed in hemorrhagic vascular beds; whether these mal-
formations progress into distinct AVMs has not been deter-
mined (Shovlin and Letarte, 1999). Our data demonstrate
that Smad7-induced arterial and venous vessel dilation can
precede shunt formation, and that shunt formation is not an
inevitable secondary consequence of vessel dilation, at least
for the duration of these experiments. Taken together, these
data suggest that shunt formation and vessel dilation can be
independent consequences of defects in TGFb signaling.
Analysis of endothelial cells of Alk1 null mutants sug-
gests that arterial/venous identity of noncapillary vessels is
never established (Urness et al., 2000). This phenotype is
thought to result, at least in part, from impaired Eph/Ephrin
signaling at the earliest stages of angiogenesis, thus leading
to a lack of mutual repulsion between arterial and venous
endothelial sprouts (Urness et al., 2000). It will be interest-
ing to determine whether similar mechanisms are impli-
cated in causing the Smad7-induced AVMs. These AVMs
all form from established vessels, and Smad7 misexpression
would thus have to repress pre-existing arterial and venous
identities, rather than inhibit their establishment. Shunting
in the cranial vasculature occurs within an individual
vessel (Fig. 4C); or between the right and left internal
carotid arteries (Fig. 4B). Thus, either distinct TGFb
signaling-dependent mechanisms cause arterial and arterio-
venous malformations, or a lack of arterio-venous distinc-
tions is not the only contributory factor in AVM formation.
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